Weimin Mao

6.0k total citations
91 papers, 1.7k citations indexed

About

Weimin Mao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Weimin Mao has authored 91 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 29 papers in Surgery. Recurrent topics in Weimin Mao's work include Lung Cancer Treatments and Mutations (35 papers), Esophageal Cancer Research and Treatment (27 papers) and Lung Cancer Diagnosis and Treatment (21 papers). Weimin Mao is often cited by papers focused on Lung Cancer Treatments and Mutations (35 papers), Esophageal Cancer Research and Treatment (27 papers) and Lung Cancer Diagnosis and Treatment (21 papers). Weimin Mao collaborates with scholars based in China, United States and Japan. Weimin Mao's co-authors include Weihui Zheng, Zhi‐Qiang Ling, Dan Su, Xiaojiang Sun, Qixun Chen, Xinmin Yu, Lisha Ying, Kaiyan Chen, Liming Sheng and Chun Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weimin Mao

88 papers receiving 1.7k citations

Peers

Countries citing papers authored by Weimin Mao

Since Specialization

Citations

This map shows the geographic impact of Weimin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weimin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weimin Mao more than expected).

Fields of papers citing papers by Weimin Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weimin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weimin Mao. The network helps show where Weimin Mao may publish in the future.

Co-authorship network of co-authors of Weimin Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Weimin Mao. A scholar is included among the top collaborators of Weimin Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weimin Mao. Weimin Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Insights into the characteristics of cancer incidence in China 2025 ·Science China Life Sciences ·Jiahui Wang, Xuping Yang, Wen‐Hui Shen, (unknown), Weimin Mao, An Zhao	0
2	Silva Classification System for HPV-Related EAC of Stage I ∼ IIIc1p Cervical Adenocarcinoma and Its Effect on Prognosis and Survival 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Jialin Li, Juwei Mu, Feng Li, Ran Li, Yiqing Du, Mei Feng, Lina Hu, Xiaoyu Tian, (unknown), Weimin Mao, Yufei Qin, Mingyang Li, Bing Lü	1
3	Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer 2022 ·Journal of Clinical Oncology ·Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Zhenfa Zhang, Bin Zhang, Changli Wang	37
4	A validation study of a continuous automatic measurement of the mechanical power in ARDS patients 2021 ·Journal of Critical Care ·Davide Chiumello, Silvia Coppola, Paolo Formenti, (unknown), (unknown), (unknown), Weimin Mao, Tommaso Pozzi	4
5	1238P Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II–IIIA (N1–N2) EGFR-mutant non-small cell lung cancer: Results from the ADJUVANT (CTONG1104) study 2020 ·Annals of Oncology ·Jing Zeng, Weimin Mao, (unknown), Ting Luo	4
6	Plasma-metabolite-based machine learning is a promising diagnostic approach for esophageal squamous cell carcinoma investigation 2020 ·Journal of Pharmaceutical Analysis ·Zhongjian Chen, Xiancong Huang, Yun Gao, Su Zeng, Weimin Mao	20
7	Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China 2019 ·Journal of Cancer ·(unknown), Xiangliu Chen, Lei Lan, Pei Li, Lian‐Lian Hong, (unknown), Weimin Mao, Ken‐ichi Mukaisho, Zhi‐Qiang Ling	2
8	Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma 2018 ·BMC Cancer ·Hongyang Lu, (unknown), (unknown), Xiaoling Tong, Fajun Xie, Jing Qin, Na Han, Xue Wu, Yun Fan, Yang Shao, Weimin Mao	20
9	CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study 2018 ·Annals of Oncology ·Wen‐Zhao Zhong, Yi‐Long Wu, (unknown), (unknown), Chundong Gu, (unknown), J. Wang, Weimin Mao, (unknown), (unknown), Lin Xu, (unknown), (unknown), Xue‐Ning Yang, (unknown), Hui Yang, Jin‐Ji Yang, Qing Zhou	7
10	Epidemiology and clinical diagnosis and treatment of malignant mesothelioma in China 2017 ·Kaiyan Chen, Zhenying Guo, Dan Su, Weimin Mao	2
11	OA08.01 Exploration of the Underlying Mechanisms of Leptomeningeal Metastasis in NSCLC Patients through NGS of Cerebrospinal Fluid 2017 ·Journal of Thoracic Oncology ·Yun Fan, Min Hu, Xuehua Zhu, Mengzhao Wang, Yanjun Xu, (unknown), Haiyan Xu, (unknown), Xin Ye, Luo Fang, Zhiyu Huang, (unknown), Lei Gong, Weimin Mao, Hongyang Lu	3
12	A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus 2016 ·Annals of Oncology ·Hao Yang, Jia Fu, (unknown), (unknown), (unknown), (unknown), Haihua Yang, Fang Wen, (unknown), Zhentao Yu, Qingsong Pang, Weimin Mao, Xiao Zheng, (unknown), (unknown), Yongtao Han	2
13	1p/19q codeletion and RET rearrangements in small-cell lung cancer 2016 ·OncoTargets and Therapy ·Hongyang Lu, Haimiao Xu, Fajun Xie, Jing Qin, Na Han, Yun Fan, Weimin Mao	2
14	Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer 2015 ·Amino Acids ·Xuli Meng, (unknown), Hongchao Tang, Weimin Mao, Hongjian Yang, Xiaojia Wang, Xianfeng Ding, (unknown)	12
15	The genotype of ribonucleotidereductase M1 -269C > A is associated with the response to platinum-based chemotherapy and as a prognostic biomarker in advanced nonsmall cell lung cancer 2015 ·Journal of Cancer Research and Therapeutics ·Xiaoling Xu, (unknown), Yun Fang, Dan Su, Wei Chen, Jianguo Feng, (unknown), Weimin Mao	2
16	The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience 2015 ·PLoS ONE ·Xiaoling Xu, Weihui Zheng, (unknown), An Zhao, Weimin Mao	12
17	A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer 2014 ·Molecular and Clinical Oncology ·Hongyang Lu, (unknown), Xiaojia Wang, (unknown), Weimin Mao	10
18	Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? 2012 ·World Journal of Surgical Oncology ·Yaping Xu, Xinmin Yu, Qixun Chen, Weimin Mao	59
19	Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment 2012 ·Oncology Letters ·Hongyang Lu, Weimin Mao, (unknown), Bo Chen, (unknown), Xiaojia Wang, Zeng Wang, Fajun Xie	20
20	Epidemiologic risk factors for esophageal cancer development. 2011 ·PubMed ·Weimin Mao, Weihui Zheng, Zhi‐Qiang Ling	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact